dipyridamole has been researched along with Albuminuria in 10 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Albuminuria: The presence of albumin in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Following a three week course of aspirin (330 mg)--dipyridamole (75 mg) taken three times daily there was significant reduction in exercise-induced albuminuria (expressed as the ratio of albumin excretion rate during exercise to that at rest before exercise) when compared to administration of placebo (P less than 0." | 9.06 | Reduction of exercise-induced albuminuria by aspirin-dipyridamole in patients with diabetes mellitus. ( Davies, JA; Hopper, AH; Tindall, H; Urquhart, S, 1987) |
| "We selected parameters (fibrinogen, micro/macroalbuminuria, ateroma in carotid artery bed) that were significantly associated with stress myocardial SPECT result." | 7.73 | [The meaning of the combination of fibrinogen, micro/macroalbuminuria and atheromatosis in the carotid bloodstream for the evaluation of the abnormal finding of the stress myocardial SPECT in the asymptomatic 2nd type diabetic patients]. ( Holá, D; Pálová, S; Zamrazil, V, 2006) |
| "The suppressive effect of dipyridamole on the proteinuria of aminonucleoside nephrosis and protamine-induced proteinuria, was investigated." | 7.66 | Suppressive effect of dipyridamole on the proteinuria of aminonucleoside nephrosis in rat. ( Endou, H; Kimura, K; Sakai, F, 1979) |
| "When treated with dipyridamole for 9." | 5.28 | Dipyridamole reduces urinary albumin excretion in diabetic patients with normo- or microalbuminuria. ( Aizawa, T; Asawa, T; Hashizume, K; Hiramatsu, K; Katakura, M; Komatsu, M; Okada, N; Shigematsu, S; Shinoda, T; Suzuki, S, 1990) |
| " Following a three week course of aspirin (330 mg)--dipyridamole (75 mg) taken three times daily there was significant reduction in exercise-induced albuminuria (expressed as the ratio of albumin excretion rate during exercise to that at rest before exercise) when compared to administration of placebo (P less than 0." | 5.06 | Reduction of exercise-induced albuminuria by aspirin-dipyridamole in patients with diabetes mellitus. ( Davies, JA; Hopper, AH; Tindall, H; Urquhart, S, 1987) |
| "We enrolled 129 patients with true RHTN regularly followed in our specialty hypertension clinic and evaluated then by resting and dipyridamole pharmacological stress myocardial perfusion scintigraphy." | 3.81 | Predictors of silent myocardial ischemia in resistant hypertensive patients. ( Barbaro, NR; Calhoun, DA; de Faria, AP; Fontana, V; Modolo, R; Moreno, H; Nascimento, BB; Paganelli, MO; Ramos, CD; Sabbatini, AR, 2015) |
| "To assess coronary blood flow velocity in young patients with type 1 DM using transoesophageal Doppler echocardiography with dipyridamole and to analyse the possible relationship between the impairment of coronary flow and retinopathy as well as microalbuminuria." | 3.74 | Association between retinopathy, microalbuminuria and coronary perfusion in young patients with type 1 diabetes mellitus. ( Biegalski, W; Dankowski, R; Kandziora, M; Michalski, M; Naskret, D; Poprawski, K; Wierzchowiecki, M, 2008) |
| "We selected parameters (fibrinogen, micro/macroalbuminuria, ateroma in carotid artery bed) that were significantly associated with stress myocardial SPECT result." | 3.73 | [The meaning of the combination of fibrinogen, micro/macroalbuminuria and atheromatosis in the carotid bloodstream for the evaluation of the abnormal finding of the stress myocardial SPECT in the asymptomatic 2nd type diabetic patients]. ( Holá, D; Pálová, S; Zamrazil, V, 2006) |
| "The suppressive effect of dipyridamole on the proteinuria of aminonucleoside nephrosis and protamine-induced proteinuria, was investigated." | 3.66 | Suppressive effect of dipyridamole on the proteinuria of aminonucleoside nephrosis in rat. ( Endou, H; Kimura, K; Sakai, F, 1979) |
| "When treated with dipyridamole for 9." | 1.28 | Dipyridamole reduces urinary albumin excretion in diabetic patients with normo- or microalbuminuria. ( Aizawa, T; Asawa, T; Hashizume, K; Hiramatsu, K; Katakura, M; Komatsu, M; Okada, N; Shigematsu, S; Shinoda, T; Suzuki, S, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Modolo, R | 1 |
| de Faria, AP | 1 |
| Paganelli, MO | 1 |
| Sabbatini, AR | 1 |
| Barbaro, NR | 1 |
| Nascimento, BB | 1 |
| Ramos, CD | 1 |
| Fontana, V | 1 |
| Calhoun, DA | 1 |
| Moreno, H | 1 |
| Taskiran, M | 1 |
| Fritz-Hansen, T | 1 |
| Rasmussen, V | 1 |
| Larsson, HB | 1 |
| Hilsted, J | 1 |
| Onozato, ML | 1 |
| Tojo, A | 1 |
| Goto, A | 1 |
| Fujita, T | 1 |
| Zamrazil, V | 1 |
| Pálová, S | 1 |
| Holá, D | 1 |
| Dankowski, R | 1 |
| Wierzchowiecki, M | 1 |
| Naskret, D | 1 |
| Michalski, M | 1 |
| Kandziora, M | 1 |
| Biegalski, W | 1 |
| Poprawski, K | 1 |
| Castells, I | 1 |
| Salinas, I | 1 |
| Rius, F | 1 |
| Fraile, M | 1 |
| Rubio, L | 1 |
| Pereferrer, D | 1 |
| Romero, R | 1 |
| Sanmartí, A | 1 |
| Kimura, K | 1 |
| Endou, H | 1 |
| Sakai, F | 1 |
| Aizawa, T | 1 |
| Suzuki, S | 1 |
| Asawa, T | 1 |
| Komatsu, M | 1 |
| Shigematsu, S | 1 |
| Okada, N | 1 |
| Katakura, M | 1 |
| Hiramatsu, K | 1 |
| Shinoda, T | 1 |
| Hashizume, K | 1 |
| Gibb, DM | 1 |
| Dunger, D | 1 |
| Levin, M | 1 |
| Grant, D | 1 |
| Jones, P | 1 |
| Barratt, TM | 1 |
| Hopper, AH | 1 |
| Tindall, H | 1 |
| Urquhart, S | 1 |
| Davies, JA | 1 |
2 trials available for dipyridamole and Albuminuria
| Article | Year |
|---|---|
Absence of effect of dipyridamole on renal and platelet function in diabetes mellitus.
Topics: Adolescent; Albuminuria; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dipyridamole; Double-Bli | 1990 |
Reduction of exercise-induced albuminuria by aspirin-dipyridamole in patients with diabetes mellitus.
Topics: Adult; Albuminuria; Aspirin; Diabetes Mellitus, Type 1; Dipyridamole; Drug Therapy, Combination; Hum | 1987 |
8 other studies available for dipyridamole and Albuminuria
| Article | Year |
|---|---|
Predictors of silent myocardial ischemia in resistant hypertensive patients.
Topics: Adult; Aged; Albuminuria; Antihypertensive Agents; Asymptomatic Diseases; Blood Pressure; Blood Pres | 2015 |
Decreased myocardial perfusion reserve in diabetic autonomic neuropathy.
Topics: Adult; Age of Onset; Albuminuria; Blood Pressure; Diabetic Neuropathies; Diabetic Retinopathy; Dipyr | 2002 |
Effect of combination therapy with dipyridamole and quinapril in diabetic nephropathy.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blotting, Western; Cr | 2003 |
[The meaning of the combination of fibrinogen, micro/macroalbuminuria and atheromatosis in the carotid bloodstream for the evaluation of the abnormal finding of the stress myocardial SPECT in the asymptomatic 2nd type diabetic patients].
Topics: Albuminuria; Atherosclerosis; Carotid Arteries; Carotid Artery Diseases; Coronary Circulation; Coron | 2006 |
Association between retinopathy, microalbuminuria and coronary perfusion in young patients with type 1 diabetes mellitus.
Topics: Adolescent; Adult; Albuminuria; Blood Flow Velocity; Coronary Circulation; Coronary Disease; Diabete | 2008 |
Inducible myocardial ischaemia in asymptomatic Type 2 diabetic patients.
Topics: Adult; Aged; Albuminuria; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Diabetic Nephr | 2000 |
Suppressive effect of dipyridamole on the proteinuria of aminonucleoside nephrosis in rat.
Topics: Albuminuria; Animals; Dipyridamole; Male; Nephrosis; Protamines; Proteinuria; Puromycin; Puromycin A | 1979 |
Dipyridamole reduces urinary albumin excretion in diabetic patients with normo- or microalbuminuria.
Topics: Adult; Aged; Albuminuria; beta 2-Microglobulin; Blood Pressure; Diabetes Complications; Diabetes Mel | 1990 |